NASDAQ: ARCT       Arcturus Therapeutics Ltd
Last Price Today's Change   Day's Range   Trading Volume
9.518   -0.152 (1.57%)  9.518 - 9.86  4,653


Avg Volume (4 weeks):56,110
4 Weeks Range:8.72 - 11.50
4 Weeks Price Volatility (%):
52 Weeks Range:4.11 - 15.50
52 Weeks Price Volatility (%):
Average Price Target: 12.00
Price Target Upside/Downside: +2.482


No recent Headlines for this stock.

Business Background

Alcobra Ltd is a biopharmaceutical company. It is focused on the development and commercialization of novel treatments for central nervous system and cognitive disorders. The company' s product candidates include Abuse-Deterrent Amphetamine Immediate-Release (ADAIR), a proprietary, abuse-deterrent oral formulation of immediate-release (short-acting) dextroamphetamine for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy; and Metadoxine Extended Release (MDX), a proprietary oral drug for the treatment of ADHD and other cognitive disorders, including Fragile X syndrome. Geographically all the operations are operated through the regions of Israel.

  Be the first to like this.


1709  3818  543  2907 

Top 10 Active Counters
 CELG 108.24+0.11 
 ACB 3.11+0.47 
 AABA 19.630.00 
 AMD 39.40-1.58 
 CHK 0.572+0.002 
 UBER 29.15+1.12 
 GGB 3.77+0.17 
 M 14.78-0.24 
 SCHW 48.29+3.54 
 ONTX 0.167-0.135 
Partners & Brokers